Sphera Funds Management Ltd. Astria Therapeutics, Inc. Transaction History
Sphera Funds Management Ltd.
- $545 Million
- Q3 2024
A detailed history of Sphera Funds Management Ltd. transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 136,582 shares of ATXS stock, worth $1.04 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
136,582
Previous 162,842
16.13%
Holding current value
$1.04 Million
Previous $1.48 Million
1.49%
% of portfolio
0.28%
Previous 0.22%
Shares
8 transactions
Others Institutions Holding ATXS
# of Institutions
108Shares Held
48.6MCall Options Held
48KPut Options Held
9.3K-
Perceptive Advisors LLC New York, NY6.49MShares$49.5 Million1.87% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.11MShares$39 Million0.78% of portfolio
-
Vestal Point Capital, LP New York, NY4MShares$30.5 Million3.34% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$27.1 Million6.36% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$26.8 Million0.0% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $116M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...